Volume VII

Issue : 16: November 5, 2009

• Apotex Loses Patent Infringement Case
• Facebook Wins $711 Million in Damages Against Spammer
• Mars Seeks Reversal of Trademark Infringement Decision
• Nokia Sues for iPhone Related Patent Infringement
• CRTCs New Net Neutrality Rules are not Without Criticism
• ICANN Approves Non Latin Script Languages for Domain Names
• UK Shop Assistant Almost Prosecuted by PRS for Singing at Work

Home > Volume VII > Issue 16: November 5, 2009 > Apotex Loses Patent Infringement Case

Apotex Loses Patent Infringement Case

A U.S. District Court has ruled that Apotex Inc., the Toronto-based generic drug manufacturer, infringed certain patents held by Irvine, California-based Allergan Inc. relating to Allergan’s Alphagan ophthalmic solution for glaucoma treatment. Apotex’s generic brimonidine product, as well as a generic product manufactured by India’s Exela PharmSci Inc., was found to infringe on the patent based on the District Court’s finding that the Allergan patents are valid and enforceable. The ruling protects Allergan’s financial interest in the Alphagan product, which Allergan expects will yield $350 million in sales for 2009. Allergan is also the maker of Botox for wrinkles.

For additional information, visit:

http://www.bloomberg.com/apps/news?pid=20601202&sid=aDnqjzUhDClk